Neurolief
About
Neurolief is a medical device company focused on developing non-invasive neuromodulation technology for the treatment of neurological and neuropsychiatric disorders. Their primary product, the Relivion system, is a brain neuromodulation device designed to provide relief for conditions such as migraine and depression by stimulating specific brain regions.
Key facts
At-a-glance profile data
- Website
- prolivrx.com
- Headquarters
- Netanya, Israel
- Founded
- 2013
- Employees
- 30
- Total funding
- $15M (Series A)
- Business model
- B2C
Funding rounds
Tech stack
Detected on prolivrx.com, last scanned 27 Aug 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- Tailwind CSS
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has Neurolief raised?
Neurolief has raised a total of $15M in funding. The most recent round on record is Series A.
How many employees does Neurolief have?
Neurolief has approximately 30 people on record.